PROVIDER PROFILE · NPI 1063457737
Dimitrios Diamandidis
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
68
Beneficiaries
—
Total drug cost
$11K
Distinct drugs
3
Brand share
19.1%
Top prescribed drugs
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where Dimitrios Diamandidis's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Clinical Laboratory · Las Vegas, NV | 67 | 401 |
| TOUROUTOGLOU, NIKOLAOS | 20 | 167 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Clinical Laboratory · Las Vegas, NV | 26 | 195 |
| Rixin Zhou Medical Oncology · Las Vegas, NV | 19 | 128 |
| Liawaty Ho Hematology-Oncology · Las Vegas, NV | 14 | 245 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE